{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T19:10:37Z","timestamp":1778094637407,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd015551","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000}}],"reference-count":152,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015551.pub2","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T08:59:17Z","timestamp":1744793957000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vaccines for preventing infections in adults with solid tumours"],"prefix":"10.1002","volume":"2025","author":[{"given":"Caroline","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Cochrane Haematology, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Mihaela","family":"Zorger","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Cochrane Haematology, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy","family":"Baumann","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Cochrane Haematology, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Soo","family":"Park","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD); Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J","family":"Br\u00f6ckelmann","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne; University of Cologne; Cologne Germany"},{"name":"Max-Planck Institute for the Biology of Ageing; Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibylle","family":"Mellinghoff","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD); Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"},{"name":"German Centre for Infection Research (DZIF), partner site; Cologne Germany"},{"name":"Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD); University of Cologne; Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Monsef","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Cochrane Haematology, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Skoetz","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Cochrane Haematology, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Kreuzberger","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Cochrane Haematology, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"10.1002\/14651858.CD015551.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/cncr.35574","article-title":"Influenza vaccine effectiveness in immunocompromised patients with cancer: a Danish nationwide register-based cohort study","volume":"22","author":"Amdisen","year":"2024","journal-title":"Cancer"},{"issue":"8","key":"10.1002\/14651858.CD015551.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/ijc.33340","article-title":"Association of postoperative influenza vaccine on overall mortality in patients undergoing curative surgery for solid tumors","volume":"148","author":"G\u00f6genur","year":"2021","journal-title":"International Journal of Cancer"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0003|cit3","unstructured":"Influence of preoperative vaccination on immune system andpostoperative infection rate in on patients with upper aerodigestive tract cancer https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2004-004352-40\/DE"},{"issue":"8","key":"10.1002\/14651858.CD015551.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/EJA.0000000000000171","article-title":"Influence of preoperative vaccination on monocytic HLA-DR expression and postoperative infection rate of patients with upper aerodigestive tract cancer","volume":"32","author":"Goldmann","year":"2015","journal-title":"European Journal of Anaesthesiology"},{"issue":"5","key":"10.1002\/14651858.CD015551.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"e002619","DOI":"10.1136\/jitc-2021-002619","article-title":"Influenza vaccine indication during therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2)","volume":"9","author":"Bersanelli","year":"2021","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0006|cit6","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920968463","article-title":"Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG","volume":"12","author":"Bersanelli","year":"2020","journal-title":"Therapeutic Advances in Medical Oncology"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"S1209","DOI":"10.1016\/j.annonc.2020.08.2323","article-title":"Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge): a FICOG study","volume":"31","author":"Bersanelli","year":"2020","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"LBA01","DOI":"10.1177\/0300891620953388","article-title":"Influenza vaccine indication during therapy with immune checkpoint inhibitors: a transversal challenge. The multicenter, prospective, observational INVIDIa-2 study (a FICOG study)","volume":"106","author":"Bersanelli","year":"2020","journal-title":"Tumori Journal"},{"issue":"15","key":"10.1002\/14651858.CD015551.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2217\/imt-2020-0211","article-title":"Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy","volume":"12","author":"Bersanelli","year":"2020","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1002\/14651858.CD015551.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/0300891620953388","article-title":"Covid-19 analysis from the multicenter, prospective, observational invidia-2 study (influenza vaccine indication during therapy with immune checkpoint inhibitors: a transversal challenge)-a FICOG study","volume":"106","author":"Buti","year":"2020","journal-title":"Tumori Journal"},{"issue":"15","key":"10.1002\/14651858.CD015551.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1200\/jco.2011.29.15_suppl.2551","article-title":"Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in adults with solid tumor malignancy (STM)","volume":"29","author":"Mullane","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD015551.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/infdis\/jit344","article-title":"Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults","volume":"208","author":"Mullane","year":"2013","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0013|cit13","unstructured":"A study of an investigational V212\/heat-treated varicella-zoster virus (VZV) vaccine in immunocompromised adults (V212-002) https:\/\/clinicaltrials.gov\/show\/NCT00535236"},{"issue":"10","key":"10.1002\/14651858.CD015551.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1016\/S1473-3099(19)30469-4","article-title":"Correction to safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial (The Lancet Infectious Diseases (2019) 19(9) (1001-1012), (S147330991930310X), (10.1016\/S1473-3099(19)30310-X))","volume":"19","year":"2019","journal-title":"Lancet Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD015551.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"ofaa172","DOI":"10.1093\/ofid\/ofaa172","article-title":"Immunogenicity of inactivated varicella zoster vaccine in autologous hematopoietic stem cell transplant recipients and patients with solid or hematologic cancer","volume":"7","author":"Boeckh","year":"2020","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0016|cit16","unstructured":"A phase III randomized, placebo-controlled, clinical trial to study the safety and efficacy of V212 in adult patients with solid tumor or hematologic malignancy https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2010-023156-89\/SK"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0017|cit17","unstructured":"A phase III randomized, placebo-controlled, clinical trial to study the safety and efficacy of V212 in adult patients with solid tumor or hematologic malignancy https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2010-023156-89-AT"},{"issue":"9","key":"10.1002\/14651858.CD015551.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S1473-3099(19)30310-X","article-title":"Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial","volume":"19","author":"Mullane","year":"2019","journal-title":"Lancet Infectious Disease"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0019|cit19","unstructured":"A study to evaluate the safety and efficacy of inactivated varicella-zoster vaccine (VZV) as a preventative treatment for herpes zoster (HZ) and HZ-related complications in adult participants with solid tumor or hematologic malignancy (V212-011) https:\/\/clinicaltrials.gov\/study\/NCT01254630"},{"issue":"40","key":"10.1002\/14651858.CD015551.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1016\/j.vaccine.2022.08.036","article-title":"Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults","volume":"40","author":"Fraiman","year":"2022","journal-title":"Vaccine"},{"issue":"7830","key":"10.1002\/14651858.CD015551.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"},{"issue":"27","key":"10.1002\/14651858.CD015551.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"19","key":"10.1002\/14651858.CD015551.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD015551.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"S1129","DOI":"10.1016\/j.annonc.2021.08.1551","article-title":"1558O COVID-19 vaccine in participants (ptcpts) with cancer: subgroup analysis of efficacy\/safety from a global phase III randomized trial of the BNT162b2 (tozinameran) mRNA vaccine","volume":"32","author":"Thomas","year":"2021","journal-title":"Annals of Oncology"},{"issue":"10","key":"10.1002\/14651858.CD015551.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.vaccine.2021.12.046","article-title":"Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial","volume":"40","author":"Thomas","year":"2022","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0026|cit26","unstructured":"Immunogenicity and safety study of GlaxoSmithKline (GSK) Biologicals? Herpes Zoster (HZ\/su) vaccine in adults with solid tumours receiving chemotherapy https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2012-002966-11"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0027|cit27","unstructured":"Immunogenicity and safety study of GlaxoSmithKline (GSK) biologicals' herpes zoster (HZ\/su) vaccine in adults with solid tumours receiving chemotherapy https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01798056"},{"issue":"8","key":"10.1002\/14651858.CD015551.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/cncr.31909","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: a randomized trial","volume":"125","author":"Vink","year":"2019","journal-title":"Cancer"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015551.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"S417","DOI":"10.1093\/ofid\/ofxl63.1045","article-title":"Immunogenicity and safety of a candidate subunit adjuvanted herpes zoster vaccine in adults with solid tumors vaccinated before or during immunosuppressive chemotherapy treatment: a phase II\/III, randomized clinical trial","volume":"4","author":"Vink","year":"2017","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejca.2018.09.012","article-title":"Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events","volume":"104","author":"Wijn","year":"2018","journal-title":"European Journal of Cancer"},{"issue":"15","key":"10.1002\/14651858.CD015551.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"e70068","DOI":"10.1002\/cam4.70068","article-title":"Efficacy and prognostic factors of COVID-19 vaccine in patients with hepatocellular carcinoma: Analysis of data from a prospective cohort study","volume":"13","author":"Zhao","year":"2024","journal-title":"Cancer Medicine"},{"issue":"5","key":"10.1002\/14651858.CD015551.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/jnci\/djad015","article-title":"COVID-19 severity by vaccination status in the NCI COVID-19 and cancer patients study (NCCAPS)","volume":"115","author":"Best","year":"2023","journal-title":"Journal of the National Cancer Institute"},{"issue":"42","key":"10.1002\/14651858.CD015551.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.15585\/mmwr.mm7142a4","article-title":"Effectiveness of COVID-19 mRNA vaccines against COVID-19-associated hospitalizations among immunocompromised adults during SARS-CoV-2 omicron predominance - VISION Network, 10 states, December 2021-August 2022","volume":"71","author":"Britton","year":"2022","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"46","key":"10.1002\/14651858.CD015551.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1016\/j.vaccine.2013.09.001","article-title":"Immunologic consequences of chemotherapy for ovarian cancer: impaired responses to the influenza vaccine","volume":"31","author":"Chu","year":"2013","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD015551.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1159\/000525962","article-title":"The effect of vaccination against COVID-19 in cancer patients: final results of the COICA trial","volume":"100","author":"Di Lorenzo","year":"2022","journal-title":"Oncology"},{"issue":"1","key":"10.1002\/14651858.CD015551.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/ajt.16641","article-title":"Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults - nine states, January-September 2021","volume":"22","author":"Embi","year":"2022","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0037|cit37","unstructured":"A phase II study to evaluate safety and efficacy to a third vaccination with an mRNA or vector vaccine in patients under immunosuppressive therapy who did not respond to standard mRNA SARS-CoV-2 (Covid-19) vaccination https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2021-002693-10-AT"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"251513552110574","DOI":"10.1177\/25151355211057479","article-title":"Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance","volume":"9","author":"Fiore","year":"2021","journal-title":"Therapeutic Advances Vaccines Immunotherapy"},{"issue":"10","key":"10.1002\/14651858.CD015551.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"S848","DOI":"10.1016\/j.jtho.2021.08.034","article-title":"OA01.01 Analysis of lung cancer patients receiving SARS-CoV-2 vaccines revealed a minority subset with poor antibody responses relative to controls","volume":"16","author":"Gomez","year":"2021","journal-title":"Journal of Thoracic Oncology"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0040|cit40","unstructured":"Vaccination response in immuno-compromised host 2 https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ISRCTN15762138"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0041|cit41","unstructured":"Efficacy of sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in the adults with immunocompromising conditions - a double blind randomized controlled trial https:\/\/jrct.niph.go.jp\/latest-detail\/jRCT1090220246"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1743-7563.2012.01578.x","article-title":"Efficacy of seasonal influenza vaccine in cancer patients undergoing chemotherapy","volume":"2","author":"Kumar","year":"2012","journal-title":"Asia-Pacific Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD015551.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"e3240","DOI":"10.1002\/hon.3240","article-title":"Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry","volume":"42","author":"Musto","year":"2024","journal-title":"Hematological Oncology"},{"issue":"10","key":"10.1002\/14651858.CD015551.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/s41416-022-01952-x","article-title":"Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer","volume":"127","author":"Cortellini","year":"2022","journal-title":"British Journal of Cancer"},{"issue":"16","key":"10.1002\/14651858.CD015551.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"e18725","DOI":"10.1200\/JCO.2022.40.16_suppl.e18725","article-title":"Clinical effectiveness of SARS-CoV-2 vaccines and booster doses in patients with cancer: an analysis from the European OnCovid registry","volume":"40","author":"Pinato","year":"2022","journal-title":"Journal of Clinial Oncology"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejca.2022.04.036","article-title":"Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer","volume":"171","author":"Pinato","year":"2022","journal-title":"European Journal of Cancer"},{"issue":"13","key":"10.1002\/14651858.CD015551.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.7150\/jca.79969","article-title":"Impact of vaccination against COVID-19 on patients with cancer in ACHOC-C19 study: Real world evidence from one Latin American country","volume":"14","author":"Ospina","year":"2023","journal-title":"Journal of Cancer"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"e17591","DOI":"10.1200\/JCO.2020.38.15_suppl.e17591","article-title":"Impact of flu vaccine on survival after immunotherapy for metastatic castration resistant prostate cancer (mCRPC): analysis of Medicare claims data","volume":"15","author":"Pachynski","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"S967","DOI":"10.1093\/ofid\/ofz360.2423","article-title":"Effectiveness of influenza vaccine for prevention of influenza-associated hospitalizations among immunocompromised adults - 2017 to 2018","volume":"6(Supplement 2)","author":"Silveira","year":"2019","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0050|cit50","unstructured":"Influence of postoperative vaccination (Mutagrip) versus and intravenous infusion of a leucocyte multiplying hormone (GM-CSF) in immune-compromised patients undergoing pancreatic or esophageal operation on the course of immunosuppression and the postoperative infection rate https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2007-003111-31\/DE"},{"issue":"3","key":"10.1002\/14651858.CD015551.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.jtho.2023.01.075","article-title":"Breakthrough SARS-CoV-2 infection and COVID-19 disease severity in lung cancer patients","volume":"18","author":"Tavolacci","year":"2023","journal-title":"Journal of Thoracic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD015551.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/CJI.0b013e31823aa41c","article-title":"Ipilimumab increases activated T cells and enhances humoral immunity in patients with advanced melanoma","volume":"35","author":"Weber","year":"2012","journal-title":"Journal of Immunotherapy"},{"issue":"1","key":"10.1002\/14651858.CD015551.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"e051254","DOI":"10.1136\/bmjopen-2021-051254","article-title":"The canadian national vaccine safety network: surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada","volume":"12","author":"Bettinger","year":"2022","journal-title":"BMJ Open"},{"issue":"196","key":"10.1002\/14651858.CD015551.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3096-7","article-title":"Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study","volume":"18","author":"Vila-Corcoles","year":"2018","journal-title":"BMC Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD015551.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"316","DOI":"10.14740\/wjon1620","article-title":"The effect of mRNA-based COVID-19 vaccination on anti-programmed cell death protein 1 blockade for nasopharyngeal cancer may differ from a virus-inactivated vaccine","volume":"14","author":"Hayashi","year":"2023","journal-title":"World Journal of Oncology"},{"issue":"7_Supplement","key":"10.1002\/14651858.CD015551.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1158\/1538-7445.AM2023-798","article-title":"SeroNet pooling project of immunocompromised populations","volume":"83","author":"Kazemain","year":"2023","journal-title":"Cancer Research"},{"issue":"16","key":"10.1002\/14651858.CD015551.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"e18731","DOI":"10.1200\/JCO.2022.40.16_suppl.e18731","article-title":"COVID-19 vaccination status and clinical outcomes in solid cancer patients treated with immune checkpoint inhibitors","volume":"40","author":"Khaddour","year":"2022","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD015551.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0277-5379(86)90367-6","article-title":"Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma","volume":"22","author":"Klastersky","year":"1986","journal-title":"European Journal of Cancer & Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD015551.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/oncolo\/oyac230","article-title":"SARS-CoV-2 vaccine immunogenicity in patients with gastrointestinal cancer receiving systemic anti-cancer therapy","volume":"28","author":"Lau","year":"2022","journal-title":"Oncologist"},{"issue":"1","key":"10.1002\/14651858.CD015551.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"2350093","DOI":"10.1080\/21645515.2024.2350093","article-title":"The effectiveness of 23-valent pneumococcal polysaccharide vaccine on elderly colorectal cancer long-term survivors: a population-based exact-matched cohort study","volume":"20","author":"Lee","year":"2024","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"5","key":"10.1002\/14651858.CD015551.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1053\/j.seminoncol.2022.07.005","article-title":"Influence of cancer on COVID-19 incidence, outcomes, and vaccine effectiveness: a prospective cohort study of U.S. veterans","volume":"49","author":"Leuva","year":"2022","journal-title":"Seminars in Oncology"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0062|cit62","unstructured":"Optimizing influenza vaccination in surgical oncology patients https:\/\/clinicaltrials.gov\/study\/NCT01698177"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0063|cit63","unstructured":"Trial of perioperative tadalafil and influenza vaccination in cancer patients undergoing major surgical resection of a primary abdominal malignancy https:\/\/clinicaltrials.gov\/show\/NCT02998736"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0064|cit64","unstructured":"Immune response to pandemische influenza A\/H1N1 vaccination in the immunocompromised https:\/\/onderzoekmetmensen.nl\/en\/node\/32477\/pdf"},{"issue":"16","key":"10.1002\/14651858.CD015551.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"e1872","DOI":"10.1200\/JCO.2022.40.16_suppl.e18721","article-title":"Effectiveness of COVID -19 vaccine on cancer patients in one Latin American country: a follow-up of ACHOC-C19 study","volume":"40","author":"Serrano","year":"2022","journal-title":"Journal of Clinical Oncology"},{"issue":"22","key":"10.1002\/14651858.CD015551.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1002\/cncr.28351","article-title":"Clinical effectiveness of seasonal influenza vaccine among adult cancer patients","volume":"119","author":"Vinograd","year":"2013","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0067|cit67","unstructured":"The impact of perioperative administration of seasonal influenza vaccine and arginine-enriched immunonutrition on perioperative immune status (PaSIVI): a feasibility and pilot study https:\/\/anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12622000706774"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0068|cit68","unstructured":"To explore the protective effect of SARS-CoV-2 vaccination on cancer patients infected with SARS-CoV-2 https:\/\/clinicaltrials.gov\/study\/NCT05774171"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0069|cit69","unstructured":"Australian Government - Department of Health Vaccination for people who are immunocompromised Australian Immunisation Handbook at health.gov.au"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ejca.2021.10.014","article-title":"Immunogenicity and risk of severe scute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection after coronavirus disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis","volume":"160","author":"Becerril-Gaitan","year":"2022","journal-title":"European Journal of Cancer"},{"issue":"11","key":"10.1002\/14651858.CD015551.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3390\/vaccines12111284","article-title":"Factors predicting COVID-19 vaccine effectiveness and longevity of humoral immune responses","volume":"12","author":"Berber","year":"2024","journal-title":"Vaccines"},{"issue":"2","key":"10.1002\/14651858.CD015551.pub2-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008983.pub3","article-title":"Influenza vaccines in immunosuppressed adults with cancer","author":"Bitterman","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0073|cit73","unstructured":"Boutron I Page MJ Higgins JPT Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies [last updated August 2022]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available at www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0074|cit74","volume-title":"TNM Classification of Malignant Tumours, 8th Edition","author":"Brierley","year":"2016"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1477-7525-1-60","article-title":"The Quality of Life Scale (QOLS): reliability, validity, and utilization","volume":"1","author":"Burckhardt","year":"2003","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0076|cit76","unstructured":"Cancer Research UK Types of infections https:\/\/www.cancerresearchuk.org\/about-cancer\/coping\/physically\/fever\/causes\/infection\/types"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0077|cit77","unstructured":"Centers for Disease Control and Prevention Vaccines & immunizations: use of COVID-19 vaccines in the United States. Interim clinical considerations https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/covid-19-vaccines-us.html"},{"issue":"3","key":"10.1002\/14651858.CD015551.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jclinepi.2019.04.002","article-title":"Established search filters may miss studies when identifying randomized controlled trials","volume":"112","author":"Cooper","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"113603","DOI":"10.1016\/j.ejca.2024.113603","article-title":"Effectiveness and safety of COVID-19 vaccination in people with blood cancer","volume":"201","author":"Copland","year":"2024","journal-title":"European Journal of Cancer"},{"issue":"6","key":"10.1002\/14651858.CD015551.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0082|cit82","unstructured":"Covidence Veritas Health Innovation"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0083|cit83","unstructured":"Deeks JJ Higgins JPT Altman DG McKenzie JE Analysing data and undertaking meta-analyses [last updated November 2024]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available at www.training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD015551.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001269.pub6","article-title":"Vaccines for preventing influenza in healthy adults","author":"Demicheli","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD015551.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/microorganisms10071450","article-title":"Viral vector vaccine development and application during the COVID-19 pandemic","volume":"10","author":"Deng","year":"2022","journal-title":"Microorganisms"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0086|cit86","unstructured":"Roadmap 2019 for research into cancer and blood diseases in Germany of the German Society for Hematology and Medical Oncology www.dgho.de\/publikationen\/stellungnahmen\/klinische-forschung\/forschungs-roadmap\/dgho_forschungs-roadmap_20190313.pdf\/view"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0087|cit87","unstructured":"European Centre for Disease Prevention and Control Vaccine-preventable diseases https:\/\/www.ecdc.europa.eu\/en\/vaccine-preventable-diseases"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0088|cit88","unstructured":"Eldridge S Campbell M Campbell M Dahota A Giraudeau B Reeves B Revised Cochrane risk of bias tool for randomized trials (RoB 2.0). Additional considerations for cluster-randomized trials (RoB 2 CRT) https:\/\/drive.google.com\/file\/d\/1yDQtDkrp68_8kJiIUdbongK99sx7RFI-\/view 2021"},{"issue":"38","key":"10.1002\/14651858.CD015551.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0959-8049(01)00448-8","article-title":"Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer","volume":"1","author":"Fayers","year":"2002","journal-title":"European Journal of Cancer"},{"issue":"6","key":"10.1002\/14651858.CD015551.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.cell.2021.02.030","article-title":"Novel approaches for vaccine development","volume":"184","author":"Gebre","year":"2021","journal-title":"Cell"},{"issue":"3","key":"10.1002\/14651858.CD015551.pub2-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.4999\/uhod.247637","article-title":"Assessment of unwanted side effects of vaccines in cancer patients: where do we stand in vaccination? Where should our next step be?","volume":"34","author":"Gecgel","year":"2024","journal-title":"International Journal of Hematology and Oncology"},{"issue":"3","key":"10.1002\/14651858.CD015551.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/hir.12269","article-title":"Translating the Cochrane EMBASE RCT filter from the Ovid interface to Embase.com: a case study","volume":"36","author":"Glanville","year":"2019","journal-title":"Health Information & Libraries Journal"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0093|cit93","unstructured":"Immunization of immunocompromised persons: canadian immunization guide https:\/\/ttpswww.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-3-vaccination-specific-populations\/page-8-immunization-immunocompromised-persons.html#a16"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0094|cit94","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"issue":"12","key":"10.1002\/14651858.CD015551.pub2-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015477","article-title":"Efficacy and safety of COVID-19 vaccines","author":"Gra\u00f1a","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0096|cit96","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024 Available at https:\/\/training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0097|cit97","unstructured":"Higgins JPT Eldridge S Li T Chapter 23: Including variants on randomized trials (last updated October 2019). In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available at https:\/\/.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0098|cit98","doi-asserted-by":"crossref","unstructured":"Higgins JPT Savovi\u0107 J Page MJ Elbers RG Sterne JAC Chapter 8: Assessing risk of bias in a randomized trial (last updated October 2019). In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available at https:\/\/.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch8"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0099|cit99","unstructured":"Higgins JPT Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect (last updated August 2023). In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available at https:\/\/training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD015551.pub2-BIB0100|cit100","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015530","article-title":"Vaccines for the prevention of infections in adults with haematological malignancies","author":"Hirsch","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD015551.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"e2331617","DOI":"10.1001\/jamanetworkopen.2023.31617","article-title":"SARS-CoV-2 infection, hospitalization, and mortality in adults with and without cancer","volume":"6","author":"Hosseini-Moghaddam","year":"2023","journal-title":"Journal of the American Medical Association Network Open"},{"issue":"8","key":"10.1002\/14651858.CD015551.pub2-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLOS Medicine"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"114501","DOI":"10.1016\/j.addr.2022.114501","article-title":"Messenger RNA-based vaccines: past, present, and future directions in the context of the COVID-19 pandemic","volume":"189","author":"Jain","year":"2021","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"860238","DOI":"10.3389\/fendo.2022.860238","article-title":"COVID-19 vaccination in patients with malignancy; a systematic review and meta-analysis of the efficacy and safety","volume":"13","author":"Javadinia","year":"2022","journal-title":"Frontiers in Endocrinology"},{"issue":"14","key":"10.1002\/14651858.CD015551.pub2-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1200\/JCO.24.00032","article-title":"Vaccination of adults with cancer: ASCO guideline","volume":"42","author":"Kamboj","year":"2024","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD015551.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1007\/s00467-023-05969-z","article-title":"Live attenuated vaccines in patients receiving immunosuppressive agents","volume":"38","author":"Kamei","year":"2023","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0107|cit107","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available at https:\/\/.training.cochrane.org\/handbook"},{"issue":"8","key":"10.1002\/14651858.CD015551.pub2-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/vaccines10081195","article-title":"Safety and efficacy of influenza vaccination in patients receiving immune checkpoint inhibitors. Systematic review with meta-analysis","volume":"10","author":"Lopez-Olivo","year":"2022","journal-title":"Vaccines"},{"issue":"5","key":"10.1002\/14651858.CD015551.pub2-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jinf.2014.05.018","article-title":"Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours","volume":"69","author":"Marin","year":"2014","journal-title":"Journal of Infection"},{"issue":"4","key":"10.1002\/14651858.CD015551.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/jrsm.1287","article-title":"Machine learning for identifying randomized controlled trials: an evaluation and practitioner's guide","volume":"9","author":"Marshall","year":"2018","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0111|cit111","unstructured":"McDonald S Noel-Storr AH Thomas J Harnessing the efficiencies of machine learning and Cochrane Crowd to identify randomised trials for individual Cochrane reviews Global Evidence Summit, 2017 Sep 13-17 Cape Town, South Africa 2017"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0112|cit112","unstructured":"McGill COVID19 Vaccine Tracker Team COVID-19 vaccine tracker covid19.trackvaccines.org\/"},{"issue":"1","key":"10.1002\/14651858.CD015551.pub2-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Research Synthesis Methods"},{"issue":"6","key":"10.1002\/14651858.CD015551.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1016\/S1473-3099(18)30601-7","article-title":"Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Mikulska","year":"2019","journal-title":"Lancet Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD015551.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0116|cit116","unstructured":"Noel-Storr AH and the Project Transform team Cochrane Crowd: new ways of working together to produce health evidence Evidence Live Oxford, UK 2018"},{"issue":"2","key":"10.1002\/14651858.CD015551.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1385\/MO:19:2:71","article-title":"Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and streptococcus pneumoniae","volume":"19","author":"Nord\u00f8y","year":"2002","journal-title":"Medical Oncology"},{"issue":"12 Pt 2","key":"10.1002\/14651858.CD015551.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.7326\/0003-4819-142-12_part_2-200506211-00011","article-title":"Challenges in using non-randomized studies in systematic reviews of treatment interventions","volume":"142","author":"Norris","year":"2005","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"British Medical Journal"},{"issue":"210","key":"10.1002\/14651858.CD015551.pub2-BIB0120|cit120","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0121|cit121","unstructured":"Page MJ Higgins JPT Sterne JAC Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis (last updated August 2024). In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available at https:\/\/training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD015551.pub2-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"101215","DOI":"10.1016\/j.esmoop.2023.101215","article-title":"Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)","volume":"8","author":"Pedrazzoli","year":"2023","journal-title":"European Society for Medical Oncology Open"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s40265-015-0449-z","article-title":"13-valent pneumococcal conjugate vaccine: a review of its use in adults","volume":"75","author":"Plosker","year":"2015","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0124|cit124","doi-asserted-by":"crossref","unstructured":"Reeves BC Deeks JJ Higgins JPT Shea B Tugwell P Wells GA Chapter 24: Including non-randomized studies on intervention effects (last updated October 2019). In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available at https:\/\/training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch24"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0125|cit125","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"6","key":"10.1002\/14651858.CD015551.pub2-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/annonc\/mdy117","article-title":"Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors\u2014guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)","volume":"29","author":"Rieger","year":"2018","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD015551.pub2-BIB0127|cit127","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40121-017-0146-1","article-title":"Infections in cancer patients with solid tumors: a review","volume":"6","author":"Rolston","year":"2017","journal-title":"Infectious Diseases and Therapy"},{"issue":"2","key":"10.1002\/14651858.CD015551.pub2-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/vaccines10020182","article-title":"Cellular immune response after vaccination in patients with cancer: review on past and present experiences","volume":"10","author":"R\u00fcthrich","year":"2022","journal-title":"Vaccines"},{"issue":"17","key":"10.1002\/14651858.CD015551.pub2-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.4254\/wjh.v7.i17.2080","article-title":"Immunology of hepatocellular carcinoma","volume":"7","author":"Sachdeva","year":"2015","journal-title":"World Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD015551.pub2-BIB0130|cit130","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40261-021-01022-9","article-title":"Can mRNA vaccines turn the tables during the COVID-19 pandemic? Current status and challenges","volume":"41","author":"Sagili Anthony","year":"2021","journal-title":"Clinical Drug Investigation"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD015551.pub2-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/jac\/dkt002","article-title":"Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance","volume":"68","author":"Schelenz","year":"2013","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jclinepi.2018.01.012","article-title":"GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in non-randomized studies should be used to rate the certainty of a body of evidence","volume":"111","author":"Sch\u00fcnemann","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0134|cit134","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence (last updated August 2023). In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available at https:\/\/.training.cochrane.org\/handbook"},{"issue":"7","key":"10.1002\/14651858.CD015551.pub2-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"e421","DOI":"10.1016\/j.clon.2023.03.006","article-title":"COVID-19 vaccination safety profiles in patients with solid tumour cancers: a systematic review","volume":"35","author":"Shear","year":"2023","journal-title":"Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD015551.pub2-BIB0136|cit136","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD015551.pub2-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0140|cit140","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jclinepi.2017.08.011","article-title":"Living systematic reviews: 2. Combining human and machine effort","volume":"91","author":"Thomas","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD015551.pub2-BIB0141|cit141","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/CJI.0000000000000424","article-title":"Influenza vaccination in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"45","author":"Tsiakos","year":"2022","journal-title":"Journal of Immunotherapy"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejca.2017.02.012","article-title":"Influenza vaccination in adult patients with solid tumours treated with chemotherapy","volume":"76","author":"Vollaard","year":"2017","journal-title":"European Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD015551.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/jrsm.1425","article-title":"Development and validation of study filters for identifying controlled non-randomized studies in PubMed and Ovid MEDLINE","volume":"11","author":"Waffenschmidt","year":"2020","journal-title":"Research Synthesis Methods"},{"issue":"6","key":"10.1002\/14651858.CD015551.pub2-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/jamia\/ocx053","article-title":"Identifying reports of randomized controlled trials (RCTs) via a hybrid machine learning and crowdsourcing approach","volume":"24","author":"Wallace","year":"2017","journal-title":"Journal of the American Medical Informatics Association"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0145|cit145","unstructured":"World Health Organization Cancer https:\/\/www.who.int\/health-topics\/cancer#tab=tab_1"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0146|cit146","unstructured":"World Health Organization Global influenza programme https:\/\/www.who.int\/teams\/global-influenza-programme\/vaccines"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0147|cit147","doi-asserted-by":"publisher","first-page":"978203","DOI":"10.3389\/fimmu.2022.978203","article-title":"Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: a systematic review and network meta-analysis","volume":"13","author":"Xia","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1002\/14651858.CD015551.pub2-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"14024","DOI":"10.1038\/s41598-021-93428-w","article-title":"Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis","volume":"11","author":"Zhang","year":"2021","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1002\/14651858.CD015551.pub2-BIB0149|cit149","doi-asserted-by":"publisher","first-page":"e00084","DOI":"10.1128\/CMR.00084-18","article-title":"Factors that influence the immune response to vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clinical Microbiology Reviews"},{"issue":"to be confirmed","key":"10.1002\/14651858.CD015551.pub2-BIB0150|cit150","article-title":"Vaccines for the prevention of infections in adults with haematological malignancies","author":"Zorger","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015551.pub2-BIB0151|cit151","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-3-319-20669-1_14","volume-title":"Infection and cancer: bi-directorial interactions","author":"Zorina","year":"2015"},{"issue":"5","key":"10.1002\/14651858.CD015551.pub2-BIB0152|cit152","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015551","article-title":"Vaccines for the prevention of infections in adults with solid tumors","author":"Bora","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T18:23:37Z","timestamp":1778091817000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015551.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":152,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015551.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}